FDA Urged to Further Loosen Limits on Data Exchange

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2qvPGWR on May 30, 2017 at 10:09AM

In comments on the FDA’s January 2016 draft payer communication guidance, stakeholders argued the need for further loosening restrictions on information exchange, and also seeked more clarity on how FDA will handle information exchange related to unapproved off-label uses of approved products. Paid subscription required to read more, here. (Source: InsideHealthPolicy, 5/30/17)